Brøsen K - Search Results

1

Drug metabolism and genetic polymorphism in subjects with previous halothane hepatitis.

Ranek L, Dalhoff K, Poulsen HE, Brøsen K, Flachs H, Loft S, Wantzin P. Ranek L, et al. Among authors: brosen k. Scand J Gastroenterol. 1993 Aug;28(8):677-80. doi: 10.3109/00365529309098271. Scand J Gastroenterol. 1993. PMID: 8210981

2

Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.

Brøsen K, Skjelbo E, Flachs H. Brøsen K, et al. Br J Clin Pharmacol. 1993 Aug;36(2):105-8. doi: 10.1111/j.1365-2125.1993.tb04204.x. Br J Clin Pharmacol. 1993. PMID: 8398577 Free PMC article.

3

Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans.

Jürgens G, Christensen HR, Brøsen K, Sonne J, Loft S, Olsen NV. Jürgens G, et al. Among authors: brosen k. Clin Pharmacol Ther. 2002 Apr;71(4):214-20. doi: 10.1067/mcp.2002.121789. Clin Pharmacol Ther. 2002. PMID: 11956503

4

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.

Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K. Jeppesen U, et al. Among authors: brosen k. Eur J Clin Pharmacol. 1996;51(1):73-8. doi: 10.1007/s002280050163. Eur J Clin Pharmacol. 1996. PMID: 8880055 Clinical Trial.

5

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine.

Rasmussen BB, Maënpää J, Pelkonen O, Loft S, Poulsen HE, Lykkesfeldt J, Brøsen K. Rasmussen BB, et al. Among authors: brosen k. Br J Clin Pharmacol. 1995 Feb;39(2):151-9. doi: 10.1111/j.1365-2125.1995.tb04422.x. Br J Clin Pharmacol. 1995. PMID: 7742153 Free PMC article.

6

Fluvoxamine is a potent inhibitor of cytochrome P4501A2.

Brøsen K, Skjelbo E, Rasmussen BB, Poulsen HE, Loft S. Brøsen K, et al. Biochem Pharmacol. 1993 Mar 24;45(6):1211-4. doi: 10.1016/0006-2952(93)90272-x. Biochem Pharmacol. 1993. PMID: 8466541

7

[Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology].

Poulsen HE, Schmitz OE, Brøsen K. Poulsen HE, et al. Among authors: brosen k. Ugeskr Laeger. 2002 Mar 18;164(12):1652. Ugeskr Laeger. 2002. PMID: 11924275 Danish. No abstract available.

8

Clinical Pharmacology in Denmark in 2016 - 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical Speciality.

Brøsen K, Andersen SE, Borregaard J, Christensen HR, Christensen PM, Dalhoff KP, Damkier P, Hallas J, Heisterberg J, Jessen N, Jürgens G, Kampmann JP, Laursen BE, Laursen T, Nielsen LP, Poulsen BK, Poulsen HE, Andersen LV, Senderovitz T, Sonne J. Brøsen K, et al. Basic Clin Pharmacol Toxicol. 2016 Dec;119(6):523-532. doi: 10.1111/bcpt.12681. Epub 2016 Oct 23. Basic Clin Pharmacol Toxicol. 2016. PMID: 27685872 Free article. Review.

9

Imipramine metabolism in relation to the sparteine oxidation polymorphism--a family study.

Madsen H, Hansen TS, Brøsen K. Madsen H, et al. Among authors: brosen k. Pharmacogenetics. 1996 Dec;6(6):513-9. doi: 10.1097/00008571-199612000-00004. Pharmacogenetics. 1996. PMID: 9014200

10

Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark.

Drøhse A, Bathum L, Brøsen K, Gram LF. Drøhse A, et al. Among authors: brosen k. Br J Clin Pharmacol. 1989 May;27(5):620-5. doi: 10.1111/j.1365-2125.1989.tb03426.x. Br J Clin Pharmacol. 1989. PMID: 2757884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters